Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 82

1.

Potential cost savings to be made by slowing cognitive decline in mild Alzheimer's disease dementia using a model derived from the UK GERAS observational study.

Lenox-Smith A, Reed C, Lebrec J, Belger M, Jones RW.

BMC Geriatr. 2018 Feb 23;18(1):57. doi: 10.1186/s12877-018-0748-9.

PMID:
29471784
2.

Attentional effects of hand proximity occur later in older adults: Evidence from event-related potentials.

Reed CL, Clay SN, Kramer AO, Leland DS, Hartley AA.

Psychol Aging. 2017 Dec;32(8):710-721. doi: 10.1037/pag0000207.

PMID:
29239656
3.

Loss Aversion Reflects Information Accumulation, Not Bias: A Drift-Diffusion Model Study.

Clay SN, Clithero JA, Harris AM, Reed CL.

Front Psychol. 2017 Oct 10;8:1708. doi: 10.3389/fpsyg.2017.01708. eCollection 2017.

4.

Embodied Valuation: Directional Action is Associated with Item Values.

Green DJ, Harris A, Young A, Reed CL.

Q J Exp Psychol (Hove). 2017 Aug 31:1-42. doi: 10.1080/17470218.2017.1360370. [Epub ahead of print]

PMID:
28856948
5.

Costs and quality of life in community-dwelling patients with Alzheimer's disease in Spain: results from the GERAS II observational study.

Olazarán J, Agüera-Ortiz L, Argimón JM, Reed C, Ciudad A, Andrade P, Dilla T.

Int Psychogeriatr. 2017 Dec;29(12):2081-2093. doi: 10.1017/S1041610217001211. Epub 2017 Jul 19.

PMID:
28720158
6.

Disease Progression in Mild Dementia due to Alzheimer Disease in an 18-Month Observational Study (GERAS): The Impact on Costs and Caregiver Outcomes.

Jones RW, Lebrec J, Kahle-Wrobleski K, Dell'Agnello G, Bruno G, Vellas B, Argimon JM, Dodel R, Haro JM, Wimo A, Reed C.

Dement Geriatr Cogn Dis Extra. 2017 Mar 20;7(1):87-100. doi: 10.1159/000461577. eCollection 2017 Jan-Apr.

7.

What Drives Country Differences in Cost of Alzheimer's Disease? An Explanation from Resource Use in the GERAS Study.

Reed C, Happich M, Argimon JM, Haro JM, Wimo A, Bruno G, Dodel R, Jones RW, Vellas B, Belger M.

J Alzheimers Dis. 2017;57(3):797-812. doi: 10.3233/JAD-160449.

PMID:
28304285
8.

How useful is the EQ-5D in assessing the impact of caring for people with Alzheimer's disease?

Reed C, Barrett A, Lebrec J, Dodel R, Jones RW, Vellas B, Wimo A, Argimon JM, Bruno G, Haro JM.

Health Qual Life Outcomes. 2017 Jan 21;15(1):16. doi: 10.1186/s12955-017-0591-2.

10.

How to deal with missing longitudinal data in cost of illness analysis in Alzheimer's disease-suggestions from the GERAS observational study.

Belger M, Haro JM, Reed C, Happich M, Kahle-Wrobleski K, Argimon JM, Bruno G, Dodel R, Jones RW, Vellas B, Wimo A.

BMC Med Res Methodol. 2016 Jul 18;16:83. doi: 10.1186/s12874-016-0188-1.

11.

Excess Costs Associated with Possible Misdiagnosis of Alzheimer's Disease Among Patients with Vascular Dementia in a UK CPRD Population.

Happich M, Kirson NY, Desai U, King S, Birnbaum HG, Reed C, Belger M, Lenox-Smith A, Price D.

J Alzheimers Dis. 2016 May 6;53(1):171-83. doi: 10.3233/JAD-150685.

12.

Effect of diabetes on caregiver burden in an observational study of individuals with Alzheimer's disease.

Lebrec J, Ascher-Svanum H, Chen YF, Reed C, Kahle-Wrobleski K, Hake AM, Raskin J, Naderali E, Schuster D, Heine RJ, Kendall DM.

BMC Geriatr. 2016 May 3;16:93. doi: 10.1186/s12877-016-0264-8.

13.

Describing the Sequence of Cognitive Decline in Alzheimer's Disease Patients: Results from an Observational Study.

Henneges C, Reed C, Chen YF, Dell'Agnello G, Lebrec J.

J Alzheimers Dis. 2016;52(3):1065-80. doi: 10.3233/JAD-150852.

14.

Holistic processing for bodies and body parts: New evidence from stereoscopic depth manipulations.

Harris A, Vyas DB, Reed CL.

Psychon Bull Rev. 2016 Oct;23(5):1513-1519.

PMID:
27001251
15.
16.

Identifying factors of activities of daily living important for cost and caregiver outcomes in Alzheimer's disease.

Reed C, Belger M, Vellas B, Andrews JS, Argimon JM, Bruno G, Dodel R, Jones RW, Wimo A, Haro JM.

Int Psychogeriatr. 2016 Feb;28(2):247-59. doi: 10.1017/S1041610215001349. Epub 2015 Aug 26.

PMID:
26307191
17.

Haptic over visual information in the distribution of visual attention after tool-use in near and far space.

Park GD, Reed CL.

Exp Brain Res. 2015 Oct;233(10):2977-88. doi: 10.1007/s00221-015-4368-8. Epub 2015 Jul 1.

PMID:
26126805
18.

Determinants of societal costs in Alzheimer's disease: GERAS study baseline results.

Dodel R, Belger M, Reed C, Wimo A, Jones RW, Happich M, Argimon JM, Bruno G, Vellas B, Haro JM.

Alzheimers Dement. 2015 Aug;11(8):933-45. doi: 10.1016/j.jalz.2015.02.005. Epub 2015 Apr 4.

PMID:
25846298
19.

Methodological challenges in assessing the impact of comorbidities on costs in Alzheimer's disease clinical trials.

Kahle-Wrobleski K, Fillit H, Kurlander J, Reed C, Belger M.

Eur J Health Econ. 2015 Dec;16(9):995-1004. doi: 10.1007/s10198-014-0648-7. Epub 2014 Nov 20.

20.

Supplemental Content

Loading ...
Support Center